Immunological challenges and therapies in xenotransplantation

Cold Spring Harbor Perspectives in Medicine

Volumn 4, Issue 4, 2014, Pages

  Vadori, Marta ^a   Cozzi, Emanuele ^a,b,c  

^a CORIT ^*  (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; BELATACEPT; EVEROLIMUS; FINGOLIMOD; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6; INTERLEUKIN 8;

CELLULAR IMMUNITY; EXTRACELLULAR MATRIX; GENETIC ENGINEERING; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL PARAMETERS; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; THROMBOTIC THROMBOCYTOPENIC PURPURA; XENOTRANSPLANTATION;

EID: 84897440998     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a015578     Document Type: Review

References (165)

1. Aksentijevich I., Sachs DH, Sykes M. 1992. Humoral tolerance in xenogeneicBMTrecipients conditioned by a nonmyeloablative regimen. Transplantation 53: 1108-1114.
2. Al-Mohanna F, Collison K, Parhar R, Kwaasi A, Meyer B, Saleh S., Allen S, al-Sedairy S, Stern D, Yacoub M. 1997. Activation of naive xenogeneic but not allogeneic endothelial cells by human naive neutrophils: A potential occult barrier to xenotransplantation. Am J Pathol 151: 111-120.
3. Al-Mohanna F, Saleh S, Parhar RS, Khabar K, Collison K. 2005. Human neutrophil gene expression profiling following xenogeneic encounter with porcine aortic endothelial cells: The occult role of neutrophils in xenograft rejection revealed. J Leukoc Biol 78: 51-61.
4. Aron Badin R, Padoan A, Vadori M, Boldrin M, Cavicchioli L, De Benedictis G, Fante F, Seveso M, Sgarabotto D, Jan C, et al. 2009. Transgenic porcine embryonic xenografts as a treatment for Parkinson's disease in non-human primates. Xenotrasplantation 16: 543.
5. Ashton-Chess J, Roussel JC, Manez R, Ruiz C, Moreau A, Cozzi E., Minault D, Soulillou JP, Blancho G. 2003. Cellular participation in delayed xenograft rejection of hCD55 transgenic pig hearts by baboons. Xenotransplantation 10: 446-453.
6. Ayares D., Phelps C, Vaught T, Ball S, Mendicino M, Ramsoondar J, Monahan J, Delong A, Walters A, Starzl T, et al. 2011. Multitrasgenic pigs for vascularized organ xenografts. Xenotransplantation 18: 269.
7. Bach F. H, Turman MA, Vercellotti GM, Platt JL, Dalmasso AP. 1991. Accommodation: Aworking paradigm for progressing toward clinical discordant xenografting. Transplant Proc 23: 205-207.
8. Basnet N. B, Ide K, Tahara H, Tanaka Y, Ohdan H. 2010. Deficiency of N-glycolylneuraminic acid and Gala1-3Galb1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies. Xenotransplantation 17: 440-448.
9. Bauer A., Postrach J, Thormann M, Blanck S, Faber C, Wintersperger B, Michel S, Abicht JM, Christ F, Schmitz C, et al. 2010. First experiencewith heterotopic thoracic pigto-baboon cardiac xenotransplantation. Xenotransplantation 17: 243-249.
10. Baumann B. C, Forte P, Hawley RJ, Rieben R, Schneider MK, Seebach J.D. 2004. Lack of galactose-a-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity. J Immunol 172: 6460-6467.
11. Baumann B. C, Stussi G, Huggel K, Rieben R, Seebach JD. 2007. Reactivity of human natural antibodies to endothelial cells from Gala(1,3)Gal-deficient pigs. Transplantation 83: 193-201.
12. Benda B., Sandberg JO, Holstad M, Korsgren O. 1998. T cells in islet-like cell cluster xenograft rejection: A study in the pig-to-mouse model. Transplantation 66: 435-440.
13. Bennet W., Groth CG, Larsson R, Nilsson B, Korsgren O. 2000. Isolated human islets trigger an instant blood mediated inflammatory reaction: Implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci 105: 125-133.
14. Blixt O., Kumagai-Braesch M, Tibellb A, Groth C, Holgerssonc J. 2009. Anticarbohydrate antibody repertoires in patients transplanted with fetal pig islets revealed by glycan arrays. Am J Transplant 9: 83-90.
15. Brandl U., Erhardt M, Michel S, Jockle H, Burdorf L, Bittmann I, Rossle M, Mordstein V, Brenner P, Hammer C, et al. 2007. Soluble Gala(1,3)Gal conjugate combined with hDAF preserves morphology and improves function of cardiac xenografts. Xenotransplantation 14: 323-332.
16. Breimer M.E. 2011. Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era. Xenotransplantation 18: 215-228.
17. Brenner P., Schmoeckel M, Wimmer C, Rucker A, Eder V, Uchita S., Brandl U, Hinz M, Felbinger T, Meiser B, et al. 2005. Combination of hDAF-transgenic pig hearts and immunoadsorption in heterotopic xenotransplantation of immunosuppressed baboons. Transplant Proc 37: 483-486.
18. Buhler L., Awwad M, Basker M, Gojo S, Watts A, Treter S, Nash K., Oravec G, Chang Q, Thall A, et al. 2000. Highdose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 69: 2296-2304.
19. Bulato C., Radu C, Simioni P. 2012. Studies on coagulation incompatibilities for xenotransplantation. Methods Mol Biol 885: 71-89.
20. Burlak C., Wang ZY, Chihara RK, Lutz AJ, Wang Y, Estrada JL, Tector A.J. 2012. Identification of human preformed antibody targets in GTKO pigs. Xenotransplantation 19: 92-101.
21. Byrne G. W, Stalboerger PG, Davila E, Heppelmann CJ, Gazi MH, McGregor HC, LaBreche PT, Davies WR, Rao VP, Oi K, et al. 2008. Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation. Xenotransplantation 15: 268-276.
22. Byrne G. W, Stalboerger PG, Du Z, Davis TR, McGregor CG. 2011. Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation. Transplantation 91: 287-292.
23. Cardona K., Korbutt GS, Milas Z, Lyon J, Cano J, Jiang W, Bello-Laborn H, Hacquoil B, Strobert E, Gangappa S, et al. 2006. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 12: 304-306.
24. Cardozo L. A, Rouw DB, Ambrose LR, Midulla M, Florey O, Haskard D. O, Warrens AN. 2004. The neutrophil: The unnoticed threat in xenotransplantation? Transplantation 78: 1721-1728.
25. Cederbom L., Hall H, Ivars F. 2000. CD4{thorn}CD25{thorn} regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 30: 1538-1543.
26. Chen G., Qian H, Starzl T, Sun H, Garcia B, Wang X, Wise Y, Liu Y., Xiang Y, Copeman L, et al. 2005. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 11: 1295-1298.
27. Chen G., Sun H, Yang H, KubelikD, Garcia B, Luo Y, Xiang Y, Qian A., Copeman L, Liu W, et al. 2006. The role of antinon-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation 81: 273-283.
28. Choo J. K, Seebach JD, Nickeleit V, Shimizu A, Lei H, Sachs DH, Madsen JC. 1997. Species differences in the expression of major histocompatibility complex class II antigens on coronary artery endothelium: Implications for cell-mediated xenoreactivity. Transplantation 64: 1315-1322.
29. Costa C., Barber DF, Fodor WL. 2002. Human NK cell-mediated cytotoxicity triggered by CD86 and Gala 1,3-Gal is inhibited in genetically modified porcine cells. J Immunol 168: 3808-3816.
30. Cowan P. J, Aminian A, Barlow H, Brown AA, Chen CG, Fisicaro N., Francis DM, Goodman DJ, Han W, Kurek M, et al. 2000. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 69: 2504-2515.
31. Cowan P. J, Robson SC, d'Apice AJ. 2011. Controlling coagulation dysregulation in xenotransplantation. Curr Opin Organ Transplant 16: 214-221.
32. Cozzi E., White DJ. 1995. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1: 964-966.
33. Cozzi E., Bhatti F, Schmoeckel M, Chavez G, Smith KG, Zaidi A, Bradley JR, Thiru S, Goddard M, Vial C, et al. 2000. Long-termsurvival of nonhuman primates receiving lifesupporting transgenic porcine kidney xenografts. Transplantation 70: 15-21.
34. Cozzi E., Vial C, Ostlie D, Farah B, Chavez G, Smith KG, Bradley J. R, Thiru S, Davies HF, Wallwork J, et al. 2003. Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts. Xenotransplantation 10: 300-310.
35. Cretin N., Bracy J, Hanson K, Iacomini J. 2002. The role of T cell help in the production of antibodies specific for Gala1-3Gal. J Immunol 168: 1479-1483.
36. Crikis S., Cowan PJ, d'Apice AJ. 2006. Intravascular thrombosis in discordant xenotransplantation. Transplantation 82: 1119-1123.
37. Dai Y., Vaught TD, Boone J, Chen SH, Phelps CJ, Ball S, Monahan J. A, Jobst PM, McCreath KJ, Lamborn AE, et al. 2002. Targeted disruption of the a1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 20: 251-255.
38. Davila E., Byrne GW, LaBreche PT, McGregor HC, Schwab AK, Davies WR, Rao VP, Oi K, Tazelaar HD, Logan JS, et al. 2006. T-cell responses during pig-to-primate xenotransplantation. Xenotransplantation 13: 31-40.
39. Diaz Varela I, Sanchez Mozo P, Centeno Cortes A, Alonso Blanco C., Valdes Canedo F. 2003. Cross-reactivity between swine leukocyte antigen and human anti-HLAspecific antibodies in sensitized patients awaiting renal transplantation. J Am Soc Nephrol 14: 2677-2683.
40. Ding Q., Lu L, Zhou X, Zhou Y, Chou KY. 2011. Human PD-L1-overexpressing porcine vascular endothelial cells induce functionally suppressive human CD4{thorn} CD25hiFoxp3{thorn} Treg cells. J Leukoc Biol 90: 77-86.
41. Diswall M., Angstrom J, Karlsson H, Phelps CJ, Ayares D, Teneberg S., Breimer ME. 2010. Structural characterization of a1,3-galactosyltransferase knockout pig heart and kidney glycolipids and their reactivity with human and baboon antibodies. Xenotransplantation 17: 48-60.
42. Diswall M., Gustafsson A, Holgersson J, Sandrin MA, Breimer M.E. 2011. Antigen-binding specificity of antiaGal reagents determined by solid-phase glycolipidbinding assays. A complete lack of aGal glycolipid reactivity in a1,3GalT-KOpig small intestine. Xenotransplantation 18: 28-39.
43. Dons E. M, Raimondi G, Cooper DK, Thomson AW. 2010. Non-human primate regulatory T cells: Current biology and implications for transplantation. Transplantation 90: 811-816.
44. Dons E. M, Montoya C, Long CE, Hara H, Echeverri GJ, Ekser B., Ezzelarab C, Medellin DR, van der Windt DJ, Murase N., et al. 2012. T-cell-based immunosuppressive therapy inhibits the development of natural antibodies in infant baboons. Transplantation 93: 769-776.
45. Dorling A., Lechler RI. 1998. T cell-mediated xenograft rejection: Specific tolerance is probably required for long term xenograft survival. Xenotransplantation 5: 234-245.
46. Dorling A., Lombardi G, Binns R, Lechler RI. 1996. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population. Eur J Immunol 26: 1378-1387.
47. Dufrane D., Goebbels RM, Saliez A, Guiot Y, Gianello P. 2006a. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: Proof of concept. Transplantation 81: 1345-1353.
48. Dufrane D., Steenberghe M, Goebbels RM, Saliez A, Guiot Y, Gianello P. 2006b. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 27: 3201-3208.
49. Dufrane D., Goebbels RM, Gianello P. 2010. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation 90: 1054-1062.
50. Ezzelarab M., Garcia B, Azimzadeh A, Sun H, Lin CC, Hara H, Kelishadi S, Zhang T, Lin YJ, Tai HC, et al. 2009. The innate immune response and activation of coagulation in a1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation 87: 805-812.
51. Ezzelarab M. B, Ekser B, Echeverri G, Hara H, Ezzelarab C, Long C., Bajona P, Garcia B, Murase N, Ayares D, et al. 2012. Costimulation blockade in pig artery patch xenotransplantation-A simple model to monitor the adaptive immune response in nonhuman primates. Xenotransplantation 19: 221-232.
52. Fang J., Walters A, Hara H, Long C, Yeh P, Ayares D, Cooper DK, Bianchi J. 2012. Anti-gal antibodies in a1,3-galactosyltransferase gene-knockout pigs. Xenotransplantation 19: 305-310.
53. Fodor W. L, Williams BL, Matis LA, Madri JA, Rollins SA, Knight J. W, VelanderW, Squinto SP. 1994. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci 91: 11153-11157.
54. Forte P., Lilienfeld BG, Baumann BC, Seebach JD. 2005. Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D. J Immunol 175: 5463-5470.
55. Fox A., Mountford J, Braakhuis A, Harrison LC. 2001. Innate and adaptive immune responses to nonvascular xenografts: Evidence that macrophages are direct effectors of xenograft rejection. J Immunol 166: 2133-2140.
56. Fu Y., Yi S, Wu J, Jimenez E, Simond D, Hawthorne WJ, O'Connell PJ. 2008. In vitro suppression of xenoimmune-mediated macrophage activation by human CD4{thorn}CD25{thorn} regulatory T cells. Transplantation 86: 865-874.
57. Galili U. 2012. Induced anti-non-gal antibodies in human xenograft recipients. Transplantation 93: 11-16.
58. Galili U., Shohet SB, Kobrin E, Stults CL, Macher BA. 1988. Man, apes, and Old World monkeys differ from other mammals in the expression of a-galactosyl epitopes on nucleated cells. J Biol Chem 263: 17755-17762.
59. Goto M., Tjernberg J, Dufrane D, Elgue G, Brandhorst D, Ekdahl K. N, Brandhorst H, Wennberg L, Kurokawa Y, Satomi S., et al. 2008. Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation. Xenotransplantation 15: 225-234.
60. Griesemer A. D, Hirakata A, Shimizu A, Moran S, Tena A, Iwaki H., Ishikawa Y, Schule P, Arn JS, Robson SC, et al. 2009. Results of Gal-knockout porcine thymokidney xenografts. Am J Transplant 9: 2669-2678.
61. Griesemer A., Liang F, Hirakata A, Hirsh E, Lo D, Okumi M, Sykes M., Yamada K, Huang CA, Sachs DH. 2010. Occurrence of specific humoral non-responsiveness to swine antigens following administration of GalT-KObone marrow to baboons. Xenotransplantation 17: 300-312.
62. Hauschild J., Petersen B, Santiago Y, Queisser AL, Carnwath JW, Lucas-Hahn A, Zhang L, Meng X, Gregory PD, Schwinzer R., et al. 2011. Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci 108: 12013-12017.
63. Hauzenberger E., Hauzenberger D, Hultenby K, Holgersson J. 2000. Porcine endothelium supports transendothelial migration of human leukocyte subpopulations: Antiporcine vascular cell adhesion molecule antibodies as species-specific blockers of transendothelial monocyte and natural killer cell migration. Transplantation 69: 1837-1849.
64. Heeger P. S, Lalli PN, Lin F, Valujskikh A, Liu J, Muqim N, Xu Y, Medof ME. 2005. Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 201: 1523-1530.
65. Hering B. J, Walawalkar N. 2009. Pig-to-nonhuman primate islet xenotransplantation. Transpl Immunol 21: 81-86.
66. Hering B. J, Wijkstrom M, Graham ML, Hardstedt M, Aasheim T. C, Jie T, Ansite JD, Nakano M, Cheng J, Li W, et al. 2006. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 12: 301-303.
67. Hisashi Y., Yamada K, Kuwaki K, Tseng YL, Dor FJ, Houser SL, Robson SC, Schuurman HJ, Cooper DK, Sachs DH, et al. 2008. Rejection of cardiac xenografts transplanted from a1,3-galactosyltransferase gene-knockout (GalTKO) pigs to baboons. Am J Transplant 8: 2516-2526.
68. Hodgson R., Christiansen D, Ziolkowski A, Mouhtouris E, Simeonovic C. J, Ierino FL, Sandrin MS. 2011. Prolonged xenograft survival induced by inducible costimulator-Ig is associated with increased Forkhead box P3{thorn} cells. Transplantation 91: 1090-1097.
69. Holgersson J., Ehrnfelt C, Hauzenberger E, Serrander L. 2002. Leukocyte endothelial cell interactions in pig to human organ xenograft rejection. Vet Immunol Immunopathol 87: 407-415.
70. Horvath-Arcidiacono JA, Porter CM, Bloom ET. 2006. Human NK cells can lyse porcine endothelial cells independent of their expression of Gala(1,3)-Gal and killing is enhanced by activation of either effector or target cells. Xenotransplantation 13: 318-327.
71. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, et al. 2006. Generation of C5a in the absence of C3: A new complement activation pathway. Nat Med 12: 682-687.
72. Ide K., Wang H, Tahara H, Liu J, Wang X, Asahara T, Sykes M, Yang Y. G, Ohdan H. 2007. Role for CD47-SIRPa signaling in xenograft rejection by macrophages. ProcNatl Acad Sci 104: 5062-5066.
73. Inverardi L., Pardi R. 1994. Early events in cell-mediated recognition of vascularized xenografts: Cooperative interactions between selected lymphocyte subsets and natural antibodies. Immunol Rev 141: 71-93.
74. Itescu S., Kwiatkowski P, Artrip JH, Wang SF, Ankersmit J, Minanov O. P, Michler RE. 1998. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Hum Immunol 59: 275-286.
75. Jackson P. G, Evans SR. 2000. Intraperitoneal macrophages and tumor immunity:Areview. J Surg Oncol 75: 146-154.
76. Karlsson-Parra A, Ridderstad A, Wallgren AC, Moller E, Ljunggren H. G, Korsgren O. 1996. Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. Transplantation 61: 1313-1320.
77. Katopodis A. G, Warner RG, Duthaler RO, Streiff MB, Bruelisauer A., Kretz O, Dorobek B, Persohn E, Andres H, Schweitzer A, et al. 2002. Removal of anti-Gala1,3Gal xenoantibodies with an injectable polymer. J Clin Invest 110: 1869-1877.
78. Kawahara T., Shimizu I, Ohdan H, Zhao G, Sykes M. 2005. Differing mechanisms of early and late B cell hyporesponsiveness induced by mixed chimerism. Am J Transplant 5: 2821-2829.
79. Kennett S. B, Porter CM, Horvath-Arcidiacono JA, Bloom ET. 2010. Characterization of baboon NK cells and their xenogeneic activity. Xenotransplantation 17: 288-299.
80. Kiernan K., Harnden I, Gunthart M, Gregory C, Meisner J, Kearns-Jonker M. 2008. The anti-non-gal xenoantibody response to xenoantigens on Gal knockout pig cells is encoded by a restricted number of germline progenitors. Am J Transplant 8: 1829-1839.
81. Kim C. H, Oh K, Kim DE, Lee SB, Yang JH, Lee G, Cho J, Lee DS. 2010. Both CD45RA{thorn} and CD45RO{thorn} human CD4{thorn} T cells drive direct xenogeneic T-cell responses against porcine aortic endothelial cells. Xenotransplantation 17: 224-232.
82. Kirchhof N., Shibata S, Wijkstrom M, Kulick DM, Salerno CT, Clemmings SM, Heremans Y, Galili U, Sutherland DE, Dalmasso AP, et al. 2004. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 11: 396-407.
83. Kirk A. D, Heinle JS, Mault JR, Sanfilippo F. 1993. Ex vivo characterization of human anti-porcine hyperacute cardiac rejection. Transplantation 56: 785-793.
84. Klymiuk N., BockerW, Schonitzer V, Bahr A, Radic T, Frohlich T, Wunsch A, Kessler B, Kurome M, Schilling E, et al. 2012. First inducible transgene expression in porcine large animal models. FASEB J 26: 1086-1099.
85. Kobayashi T., Taniguchi S, Neethling FA, Rose AG, Hancock WW, Ye Y, Niekrasz M, Kosanke S, Wright LJ, White DJ, et al. 1997. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 64: 1255-1261.
86. Koch C. A, Khalpey ZI, Platt JL. 2004. Accommodation: Preventing injury in transplantation and disease. J Immunol 172: 5143-5148.
87. Konakci K. Z, Bohle B, Blumer R, Hoetzenecker W, Roth G, Moser B., Boltz-Nitulescu G, Gorlitzer M, Klepetko W, Wolner E., et al. 2005. a-Gal on bioprostheses: Xenograft immune response in cardiac surgery. Eur J Clin Invest 35: 17-23.
88. Koshika T., Phelps C, Fang J, Lee SE, Fujita M, Ayares D, Cooper D. K, Hara H. 2011. Relative efficiency of porcine and human cytotoxic T-lymphocyte antigen 4 immunoglobulin in inhibiting human CD4{thorn} T-cell responses costimulated by porcine and human B7 molecules. Immunology 134: 386-397.
89. Kuwaki K., Tseng YL, Dor FJ, Shimizu A, Houser SL, Sanderson TM, Lancos CJ, PrabharasuthDD, Cheng J, Moran K, et al. 2005. Heart transplantation in baboons using a1,3-galactosyltransferase gene-knockout pigs as donors: Initial experience. Nat Med 11: 29-31.
90. Kwan W. H, van der TouwW, Heeger PS. 2012. Complement regulation of T cell immunity. Immunol Res 54: 247-253.
91. Lai L., Kolber-Simonds D, Park KW, Cheong HT, Greenstein JL, Im GS, Samuel M, Bonk A, Rieke A, Day BN, et al. 2002. Production of a-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295: 1089-1092.
92. Lam T. T, Paniagua R, Shivaram G, Schuurman HJ, Borie DC, Morris R.E. 2004. Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAFtransgenic porcine hearts in cynomolgus monkeys. Xenotransplantation 11: 531-535.
93. Lam T. T, Hausen B, Hook L, Lau M, Higgins J, Christians U, Jacobsen W., Baluom M, Duthaler R, Katopodis A, et al. 2005. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts. Xenotransplantation 12: 20-29.
94. Le Bas-Bernardet S, Tillou X, Poirier N, Dilek N, Chatelais M, Devalliere J, Charreau B, Minault D, Hervouet J, Renaudin K, et al. 2011. Xenotransplantation of galactosyltransferase knockout, CD55, CD59, CD39, and fucosyltransferase transgenic pig kidneys into baboons. Transplant Proc 43: 3426-3430.
95. Lilienfeld B. G, Garcia-Borges C, Crew MD, Seebach JD. 2006. Porcine UL16-binding protein 1 expressed on the surface of endothelial cells triggers human NK cytotoxicity through NKG2D. J Immunol 177: 2146-2152.
96. Lin Y. J, Hara H, Tai HC, Long C, Tokita D, Yeh P, Ayares D, Morelli A. E, Cooper DK. 2008. Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses. Transplantation 86: 1452-1462.
97. Lin C. C, Cooper DK, Dorling A. 2009. Coagulation dysregulation as a barrier to xenotransplantation in the primate. Transpl Immunol 21: 75-80.
98. Ljunggren H. G, Karre K. 1990. In search of the "missing self ":MHCmolecules and NK cell recognition. Immunol Today 11: 237-244.
99. Loveland B. E, Milland J, Kyriakou P, Thorley BR, ChristiansenD, Lanteri M. B, Regensburg M, Duffield M, French AJ, Williams L., et al. 2004. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Xenotransplantation 11: 171-183.
100. Lutz A. J, Li P, Estrada JL, Sidner RA, Chihara RK, Downey SM, Burlak C, Wang ZY, Reyes LM, Ivary B, et al. 2013. Double knockout pigs deficient in N-glycolylneuraminic acid and galactose a-1,3-galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation 20: 27-35.
101. Macher B. A, Galili U. 2008. The Gala1,3Galb1,4GlcNAc-R (a-Gal) epitope: Acarbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta 1780: 75-88.
102. Martin C., Plat M, Nerriere-Daguin V, Coulon F, Uzbekova S, Venturi E., Conde F, Hermel JM, Hantraye P, Tesson L, et al. 2005. Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation. Transgenic Res 14: 373-384.
103. McCurry KR, Kooyman DL, Alvarado CG, Cotterell AH, Martin M. J, Logan JS, Platt JL. 1995. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1: 423-427.
104. McGregor CG, Davies WR, Oi K, Teotia SS, Schirmer JM, Risdahl J. M, Tazelaar HD, Kremers WK, Walker RC, Byrne R. W, et al. 2005. Cardiac xenotransplantation: Recent preclinical progress with 3-month median survival. J Thorac Cardiovasc Surg 130: 844-851.
105. McMorrow IM, Comrack CA, Sachs DH, DerSimonian H. 1997. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(a1,3)Galactose epitope. Transplantation 64: 501-510.
106. McPherson TB, Liang H, Record RD, Badylak SF. 2000. Gala(1,3)Gal epitope in porcine small intestinal submucosa. Tissue Eng 6: 233-239.
107. Menoret S., Plat M, Blancho G, Martinat-Botte F, Bernard P, Karam G., Tesson L, Renaudin K, Guillouet P, Weill B, et al. 2004. Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-tobaboon combination. Transplantation 77: 1468-14671.
108. Mohiuddin M. M, Corcoran PC, Singh AK, Azimzadeh A, Hoyt R. F Jr, Thomas ML, Eckhaus MA, Seavey C, Ayares D, PiersonRNIII, et al. 2012. B-cell depletion extends the survival of GTKO. hCD46Tg pig heart xenografts in baboons for up to 8 months. Am J Transplant 12: 763-771.
109. Mulder A., Kardol MJ, Arn JS, Eijsink C, Franke ME, Schreuder G. M, Haasnoot GW, Doxiadis II, Sachs DH, Smith D. M, et al. 2010. Human monoclonal HLA antibodies reveal interspecies crossreactive swineMHCclass I epitopes relevant for xenotransplantation. Mol Immunol 47: 809-815.
110. MullerYD, Seebach JD, Buhler LH, Pascual M, GolshayanD. 2011. Transplantation tolerance: Clinical potential of regulatory T cells. Self Nonself 2: 26-34.
111. Muller Y. D, Ehirchiou D, Golshayan D, Buhler LH, Seebach JD. 2012. Potential of T-regulatory cells to protect xenografts. Curr Opin Organ Transplant 17: 155-161.
112. Naziruddin B., Durriya S, Phelan D, Duffy BF, Olack B, Smith D., Howard T, Mohanakumar T. 1998. HLA antibodies present in the sera of sensitized patients awaiting renal transplant are also reactive to swine leukocyte antigens. Transplantation 66: 1074-1080.
113. Nishimura T., Onda M, Takao S. 2010. CD4{thorn} CD25{thorn} regulatory T cells suppressed the indirect xenogeneic immune response mediated by porcine epithelial cell pulsed dendritic cells. Xenotransplantation 17: 313-323.
114. Ohdan H., Yang YG, Shimizu A, Swenson KG, Sykes M. 1999. Mixed chimerism induced without lethal conditioning prevents T cell-and anti-Gala1,3Gal-mediated graft rejection. J Clin Invest 104: 281-290.
115. Padler-Karavani V, Yu H, Cao H, Chokhawala H, Karp F, Varki N., Chen X, Varki A. 2008. Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease. Glycobiology 18: 818-830.
116. Park J. Y, Park MR, Kwon DN, KangMH, Oh M, HanJW, Cho SG, Park C, Kim DK, Song H, et al. 2011. a1,3-Galactosyltransferase deficiency in pigs increases sialyltransferase activities that potentially raise non-gal xenoantigenicity. J Biomed Biotechnol 2011: 560850.
117. Park J. Y, Park MR, Bui HT, Kwon DN, Kang MH, Oh M, Han JW, Cho SG, Park C, Shim H, et al. 2012. a1,3-Galactosyltransferase deficiency in germ-free miniature pigs increases N-glycolylneuraminic acids as the xenoantigenic determinant in pig-human xenotransplantation. Cell Reprogram 14: 353-363.
118. Parker W., Bruno D, Holzknecht ZE, Platt JL. 1994. Characterization and affinity isolation of xenoreactive human natural antibodies. J Immunol 153: 3791-3803.
119. Phelps C. J, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, Ball S, Specht SM, Polejaeva IA, Monahan JA, et al. 2003. Production of a1,3-galactosyltransferase-deficient pigs. Science 299: 411-414.
120. Phelps C. J, Ball SF, Vaught TD, Vance AM, Mendicino M, Monahan J. A, Walters AH, Wells KD, Dandro AS, Ramsoondar JJ, et al. 2009. Production and characterization of transgenic pigs expressing porcine CTLA4-Ig. Xenotransplantation 16: 477-485.
121. Puga Yung GL, Li Y, Borsig L, Millard AL, Karpova MB, Zhou D., Seebach JD. 2012. Complete absence of the aGal xenoantigen and isoglobotrihexosylceramide in a1,3galactosyltransferase knock-out pigs. Xenotransplantation 19: 196-206.
122. Rogers N. J, Jackson IM, Jordan WJ, Hawadle MA, Dorling A, Lechler R.I. 2003. Cross-species costimulation: Relative contributions of CD80, CD86, and CD40. Transplantation 75: 2068-2076.
123. Saethre M., Schneider MK, Lambris JD, Magotti P, Haraldsen G, Seebach JD, Mollnes TE. 2008. Cytokine secretion depends on Gala(1,3)Gal expression in a pig-to-human whole blood model. J Immunol 180: 6346-6353.
124. Schmelzle M., Schulte Esch J II, Robson SC. 2010. Coagulation, platelet activation and thrombosis in xenotransplantation. Curr Opin Organ Transplant 15: 212-218.
125. Schneider M. K, Seebach JD. 2008. Current cellular innate immune hurdles in pig-to-primate xenotransplantation. Curr Opin Organ Transplant 13: 171-177.
126. Schneider M. K, Ghielmetti M, Rhyner DM, Antsiferova MA, Seebach J.D. 2009. Human leukocyte transmigration across Gala(1,3)Gal-negative porcine endothelium is regulated by human CD18 and CD99. Transplantation 87: 491-499.
127. Scobie L., Padler-Karavani V, Le Bas-Bernardet S, Crossan C, Blaha J., Matouskova M, Hector RD, Cozzi E, Vanhove B, Charreau B., et al. 2013. Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. J Immunol 191: 2907-2915.
128. Sharma A., Naziruddin B, Cui C, Martin MJ, Xu H, Wan H, Lei Y., Harrison C, Yin J, Okabe J, et al. 2003. Pig cells that lack the gene for a1-3 galactosyltransferase express low levels of the Gal antigen. Transplantation 75: 430-436.
129. Sheikh S., Parhar R, Al-Mohanna F. 2002. Rapid static adhesion of human naive neutrophil to naive xenoendothelium under physiologic flow is independent of Gala1,3-gal structures. J Leukoc Biol 71: 932-940.
130. Shimizu I., Kawahara T, Haspot F, Bardwell PD, Carroll MC, Sykes M. 2007. B-cell extrinsic CR1/CR2 promotes natural antibody production and tolerance induction of anti-aGAL-producing B-1 cells. Blood 109: 1773-1781.
131. Shimizu A., Hisashi Y, Kuwaki K, Tseng YL, Dor FJ, Houser SL, Robson SC, Schuurman HJ, Cooper DK, Sachs DH, et al. 2008. Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from a1,3-galac-tosyltransferase gene-knockout pigs in baboons. Am J Pathol 172: 1471-1481.
132. Shimizu A., Yamada K, Robson SC, Sachs DH, Colvin RB. 2012. Pathologic characteristics of transplanted kidney xenografts. J Am Soc Nephrol 23: 225-235.
133. Singh A. K, Seavey CN, Horvath KA, Mohiuddin MM. 2012. Ex-vivo expanded baboon CD4{thorn} CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response. Xenotransplantation 19: 102-111.
134. Sommaggio R., Cohnen A, Watzl C, Costa C. 2012. Multiple receptors trigger human NK cell-mediated cytotoxicity against porcine chondrocytes. J Immunol 188: 2075-2083.
135. Stevens R. B, Platt JL. 1992. The pathogenesis of hyperacute xenograft rejection. Am J Kidney Dis 20: 414-421.
136. Stone K. R, Walgenbach AW, Turek TJ, Somers DL, Wicomb W, Galili U. 2007. Anterior cruciate ligament reconstructionwith a porcine xenograft: A serologic, histologic, and biomechanical study in primates. Arthroscopy 23: 411-419.
137. Tahara H., Ide K, Basnet N, Tanaka Y, Ohdan H. 2010. Determination of the precursor frequency and the reaction intensity of xenoreactive human T lymphocytes. Xenotransplantation 17: 188-196.
138. Tahiri F., Li Y, Hawke D, Ganiko L, Almeida I, Levery S, Zhou D. 2013. Lack of iGb3 and Isoglobo-series glycosphingolipids in pig organs used for xenotransplantation: Implications for natural killer T-cell biology. J Carbohydr Chem 32: 44-67.
139. Tanemura M., Yin D, Chong AS, Galili U. 2000. Differential immune responses to a-Gal epitopes on xenografts and allografts: Implications for accommodation in xenotransplantation. J Clin Invest 105: 301-310.
140. Tanemura M., Ogawa H, Yin DP, Chen ZC, DiSesa VJ, Galili U. 2002. Elimination of anti-Gal B cells by a-Gal ricin1. Transplantation 73: 1859-1868.
141. Taylor C. J, Tang KG, Smith SI, White DJ, Davies HF. 1998. HLA-specific antibodies in highly sensitized patients can cause a positive crossmatch against pig lymphocytes. Transplantation 65: 1634-1641.
142. Tazelaar H. D, Byrne GW, McGregor CG. 2011. Comparison of Gal and non-Gal-mediated cardiac xenograft rejection. Transplantation 91: 968-975.
143. Tena A., Turcotte N, Leto Barone A, Arn S, Terlouw S, Dobrinsky J, Sachs D, Hawley R. 2011. Miniature swine expressing human CD47 to enhance bone marrow engraftment in non-human primates. Xenotransplantation 18: 271.
144. Thompson P., Badell IR, Lowe M, Cano J, Song M, Leopardi F, Avila J, Ruhil R, Strobert E, Korbutt G, et al. 2011a. Islet xenotransplantation using Gal-deficient neonatal donors improves engraftment and function. Am J Transplant 11: 2593-2602.
145. Thompson P., Cardona K, Russell M, Badell IR, Shaffer V, Korbutt G., Rayat GR, Cano J, Song M, Jiang W, et al. 2011b. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant 11: 947-957.
146. Tseng Y. L, Dor FJ, Kuwaki K, Ryan D, Wood J, Denaro M, Giovino M., Yamada K, Hawley R, Patience C, et al. 2004. Bone marrow transplantation from a1,3-galactosyltransferase gene-knockout pigs in baboons. Xenotransplantation 11: 361-370.
147. van derWindt DJ, Bottino R, Casu A, Campanile N, Cooper DK. 2007. Rapid loss of intraportally transplanted islets: An overview of pathophysiology and preventive strategies. Xenotransplantation 14: 288-297.
148. van der Windt DJ, Bottino R, Casu A, Campanile N, Smetanka C, He J, Murase N, Hara H, Ball S, Loveland BE, et al. 2009. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 9: 2716-2726.
149. Varki A. 2010. Colloquium paper: Uniquely human evolution of sialic acid genetics and biology. Proc Natl Acad Sci 107: 8939-8946.
150. Vercellotti G. M, Platt JL, Bach FH, Dalmasso AP. 1991. Neutrophil adhesion to xenogeneic endothelium via iC3b. J Immunol 146: 730-734.
151. Vugmeyster Y., Beyer J, Howell K, Combs D, Fielder P, Yang J, Qureshi F., Sandlund B, Kawaguchi L, Dummer W, et al. 2005. Depletion of B cells by a humanized anti-CD20 antibody PRO70769 inMacaca fascicularis. J Immunother 28: 212-219.
152. Wallgren A. C, Karlsson-Parra A, KorsgrenO. 1995. The main infiltrating cell in xenograft rejection is a CD4{thorn} macrophage and not a T lymphocyte. Transplantation 60: 594-601.
153. Weiss E. H, Lilienfeld BG, Muller S, Muller E, Herbach N, Kessler B., Wanke R, Schwinzer R, Seebach JD, Wolf E, et al. 2009. HLA-E/human b2-microglobulin transgenic pigs: Protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation 87: 35-43.
154. Wilhite T., Ezzelarab C, Hara H, Long C, Ayares D, Cooper DK, Ezzelarab M. 2012. The effect of Gal expression on pig cells on the human T-cell xenoresponse. Xenotransplantation 19: 56-63.
155. Wu J., Yi S, Ouyang L, Jimenez E, Simond D, WangW, Wang Y, Hawthorne WJ, O'Connell PJ. 2008. In vitro expanded human CD4{thorn}CD25{thorn} regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses. Transplantation 85: 1841-1848.
156. Xu X. C, Goodman J, Sasaki H, Lowell J, Mohanakumar T. 2002. Activation of natural killer cells and macrophages by porcine endothelial cells augments specific T-cell xenoresponse. Am J Transplant 2: 314-322.
157. Xu Y., Yang YG, Ohdan H, Ryan D, Harper D, Wu C, Kruger-Grey H. S, Thall AD, Awwad M, Sykes M. 2006. Characterization of anti-Gal antibody-producing cells of baboons and humans. Transplantation 81: 940-948.
158. Yamada K., Sachs DH, DerSimonian H. 1995. Human antiporcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 155: 5249-5256.
159. Yamada K., Yazawa K, Shimizu A, Iwanaga T, Hisashi Y, Nuhn M, O'Malley P, Nobori S, Vagefi PA, Patience C, et al. 2005. Marked prolongation of porcine renal xenograft survival in baboons through the use of a1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 11: 32-34.
160. Yamamoto S., Lavelle JM, Vagefi PA, Arakawa H, Samelson-Jones E., Moran S, Teranishi K, Kamano C, Fishman J, Awwad M., et al. 2005. Vascularized thymic lobe transplantation in a pig-to-baboon model: A novel strategy for xenogeneic tolerance induction and T-cell reconstitution. Transplantation 80: 1783-1790.
161. Yang Y. G, deGoma E, Ohdan H, Bracy JL, Xu Y, Iacomini J, ThallAD, Sykes M. 1998. Tolerization of anti-Gala1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med 187: 1335-1342.
162. Yeh P., Ezzelarab M, Bovin N, Hara H, Long C, Tomiyama K, Sun F., Ayares D, Awwad M, Cooper DK. 2010. Investigation of potential carbohydrate antigen targets for human and baboon antibodies. Xenotransplantation 17: 197-206.
163. Yi S., Feng X, Hawthorne WJ, Patel AT, Walters AN, O'Connell PJ. 2002. CD4{thorn} T cells initiate pancreatic islet xenograft rejection via an interferon-g-dependent recruitment of macrophages and natural killer cells. Transplantation 73: 437-446.
164. Yi S., Hawthorne WJ, Lehnert AM, Ha H, Wong JK, van Rooijen N., Davey K, Patel AT, Walters SN, Chandra A, et al. 2003. T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 170: 2750-2758.
165. Zhao Y., Swenson K, Sergio JJ, Arn JS, Sachs DH, Sykes M. 1996. Skin graft tolerance across a discordant xenogeneic barrier. Nat Med 2: 1211-1216.